The Uricosuric Effect of SGLT2 Inhibitors Is Maintained in the Long Term in Patients with Chronic Kidney Disease and Type 2 Diabetes Mellitus

The Uricosuric Effect of SGLT2 Inhibitors Is Maintained in the Long Term in Patients with Chronic Kidney Disease and Type 2 Diabetes Mellitus

(1) Background: Sodium–glucose co-transporter 2 inhibitors (SGLT2is) increase uric acid excretion. The intensity of uricosuria is linked to glycosuria. (2) Methods: We aim to analyze the effect of SGLT2 inhibitors on urinary fractional excretion (FE) of uric acid and glucose in patients with type 2...

Full description

Bibliographic Details
Main Authors: Paula Sánchez-Briales, María Marques Vidas, Paula López-Sánchez, María Victoria López-Illázquez, Lucía Martín-Testillano, Aylin Vedat-Ali, Jose Portolés
Format: Article
Language:English
Published: MDPI AG 2024-02-01
Series:Journal of Clinical Medicine
Subjects:
chronic kidney disease
fractional excretion
SGLT2 inhibitors
type 2 diabetes mellitus
uric acid
Online Access:https://www.mdpi.com/2077-0383/13/5/1360

Similar Items

Similar Items